Insider · CIK 0001813162
Margrave David R.
Reports to the SEC for 1 company · DALLAS, TX
Transactions
8
Companies
1
Filings
5
CIK
0001813162
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2025-12-18 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-07-15 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-10-29 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-10-29 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2021-10-29 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-06-15 | LTRNLantern Pharma Inc. · Stock OptionA Award | — |
| 2020-06-15 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-06-15 | LTRNLantern Pharma Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Margrave David R.0001493152-25-028759SEC(opens sec.gov)
- 4Margrave David R.0001493152-25-014612SEC(opens sec.gov)
- 4Margrave David R.0001493152-24-028186SEC(opens sec.gov)
- 4Margrave David R.0001213900-21-056108SEC(opens sec.gov)
- 4Margrave David R.0001213900-20-015047SEC(opens sec.gov)
Companies
Address
1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS, TX, 75201